JLE

Hépato-Gastro & Oncologie Digestive

MENU

Les erreurs à ne pas faire devant une insuffisance hépatique aiguë Volume 26, supplément 2, Novembre 2019

  • [1] Paugam-Burtz C, Levesque E, Louvet A, et al. Liver failure in intensive care unit, Recommendations formalisées d’experts, SFAR-AFEF, 2018.
  • [2] Bernuau J., Rueff B., Benhamou J.P. Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis. 1986;6:97-106.
  • [3] O’Grady J.G., Schalm S.W., Williams R. Acute liver failure: Redefining the syndromes. Lancet Lond Engl. 1993;342:273-275.
  • [4] Mochida S., Nakayama N., Matsui A. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008;38:970-979.
  • [5] Fyfe B., Zaldana F., Liu C. The Pathology of Acute Liver Failure. Clin Liver Dis. 2018;22:257-268.
  • [6] Antoniades C.G., Berry P.A., Wendon J.A. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49:845-861.
  • [7] Taylor N.J., Nishtala A., Manakkat Vijay G.K. Circulating neutrophil dysfunction in acute liver failure. Hepatol Baltim Md. 2013;57:1142-1152.
  • [8] Ichai P, Legeai C, Francoz C, et al. Patients with acute liver failure listed for superurgent liver transplantation in France: Reevaluation of the Clichy-Villejuif criteria. Liver Transplant 2015 ; 21 : 512-23.
  • [9] de Andrade K.Q., Moura F.A., dos Santos J.M. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic possibilities of N-acetylcysteine. Int J Mol Sci. 2015;16:30269-30308.
  • [10] Harrison P.M., Keays R., Bray G.P. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet Lond Engl. 1990;335:1572-1573.
  • [11] Lee W.M., Hynan L.S., Rossaro L. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-864.
  • [12] Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013 ; 369 : 2525-34.
  • [13] European Association for the Study of the Liver. Clinical practice guidelines panel, Wendon, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017 ; 66 : 1047-81.
  • [14] Stravitz R.T., Ellerbe C., Durkalski V. Bleeding complications in acute liver failure. Hepatol Baltim Md. 2018;67:1931-1942.
  • [15] Vaquero J., Fontana R.J., Larson A.M. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11:1581-1589.
  • [16] Murphy N., Auzinger G., Bernel W. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatol Baltim Md. 2004;39:464-470.
  • [17] Bernal W., Hyyrylainen A., Gera A. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74-80.
  • [18] Francoz C, Houssel P, Pironti A, et al. JFHOD. P125-Place de la transplantation hépatique pour insuffisance héaptique aiguë secondaire à une intoxication par le paracétamol. Disponible à l’adresse suivante : https://www.snfge.org/content/place-de-la-transplantation-hepatique-pour-insu.
  • [19] Escudié L., Francoz C., Vinel J.-P. Amanita phalloides poisoning: Reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol. 2007;46:466-473.